Incyte (INCY) PT Lowered to $78 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Tweet
Share
E-mail
Get Alerts INCY Hot Sheet
Price: $116.87 +0.23%
Rating Summary:
18 Buy, 17 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 6
Rating Summary:
18 Buy, 17 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 6
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on Incyte (NASDAQ: INCY) to $78.00 (from $79.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Reiterates Buy Rating on Incyte (INCY)
- Generac Holdings (GNRC) PT Raised to $325 at Stifel
- BMO Capital on Incyte (INCY): 'ESMO Event Builds Solid-Tumor Confidence'
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
